Reported 6,602,306 shares, up 645,613 (10.8%) from the prior quarter.
Reported value -18.1%; share count 10.8% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-03-31 | 210271000 |
| 2021-06-30 | 172189000 |
| 2021-09-30 | 172080000 |
| 2021-12-31 | 100588000 |
| 2022-03-31 | 61529000 |
| 2022-06-30 | 95830000 |
| 2022-09-30 | 77362000 |
| 2022-12-31 | 45698239 |
| 2023-03-31 | 36088360 |
| 2023-06-30 | 37282420 |
| 2023-09-30 | 33563338 |
| 2023-12-31 | 28988948 |
| 2024-03-31 | 36687811 |
| 2024-06-30 | 19095902 |
| 2024-09-30 | 23317557 |
| 2024-12-31 | 17041474 |
| 2025-03-31 | 11778627 |
| 2025-06-30 | 9332815 |
| 2025-09-30 | 11185755 |
| 2025-12-31 | 12674704 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2025 | Added | 9,251,609 | +230,839 (2.6%) | < 0.01% | $12,674,704 | 2026-01-29 | |
| Q3 2025 | Added | 9,020,770 | +761,642 (9.2%) | < 0.01% | $11,185,755 | 2025-11-07 | |
| Q2 2025 | Added | 8,259,128 | +191,575 (2.4%) | < 0.01% | $9,332,815 | 2025-08-11 | |
| Q1 2025 | Added | 8,067,553 | +66,861 (0.8%) | < 0.01% | $11,778,627 | 2025-05-09 | |
| Q4 2024 | Reduced | 8,000,692 | -327,007 (-3.9%) | < 0.01% | $17,041,474 | 2025-02-11 | |
| Q3 2024 | Added | 8,327,699 | +132,033 (1.6%) | < 0.01% | $23,317,557 | 2024-11-13 | |
| Q2 2024 | Reduced | 8,195,666 | -11,898 (-0.1%) | < 0.01% | $19,095,902 | 2024-08-13 | |
| Q1 2024 | Reduced | 8,207,564 | -823,261 (-9.1%) | < 0.01% | $36,687,811 | 2024-05-10 | |
| Q4 2023 | Reduced | 9,030,825 | -1,556,979 (-14.7%) | < 0.01% | $28,988,948 | 2024-02-14 | |
| Q3 2023 | Added | 10,587,804 | +3,086,311 (41.1%) | < 0.01% | $33,563,338 | 2023-11-14 | |
| Q2 2023 | Added | 7,501,493 | +196,157 (2.7%) | < 0.01% | $37,282,420 | 2023-08-14 | |
| Q1 2023 | Added | 7,305,336 | +40,115 (0.6%) | < 0.01% | $36,088,360 | 2023-05-15 | |
| Q4 2022 | Added | 7,265,221 | +102,139 (1.4%) | < 0.01% | $45,698,239 | 2023-02-10 | |
| Q3 2022 | Reduced | 7,163,082 | -1,243,065 (-14.8%) | < 0.01% | $77,362,000 | 2022-11-14 | |
| Q2 2022 | Added | 8,406,147 | +1,652,167 (24.5%) | < 0.01% | $95,830,000 | 2022-08-12 | |
| Q1 2022 | Added | 6,753,980 | +12,141 (0.2%) | < 0.01% | $61,529,000 | 2022-05-13 | |
| Q4 2021 | Added | 6,741,839 | +46,119 (0.7%) | < 0.01% | $100,588,000 | 2022-02-14 | |
| Q3 2021 | Added | 6,695,720 | +93,414 (1.4%) | < 0.01% | $172,080,000 | 2021-11-12 | |
| Q2 2021 | Added | 6,602,306 | +645,613 (10.8%) | < 0.01% | $172,189,000 | 2021-08-13 | |
| Q1 2021 | Added | 5,956,693 | +170,216 (2.9%) | < 0.01% | $210,271,000 | 2021-05-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
197 managers reported ALLOGENE THERAPEUTICS INC for Q2 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 7,021,939 | +751,861 | < 0.01% | $183,132,000 | 11 qtrs |
| VANGUARD GROUP INC This report | Added | 6,602,306 | +645,613 | < 0.01% | $172,189,000 | 11 qtrs |
| Capital Research Global Investors | Reduced | 5,404,300 | -7,259,713 | 0.03% | $140,944,000 | 11 qtrs |
| PRIMECAP MANAGEMENT CO CA | Added | 3,577,030 | +2,271,630 | 0.06% | $93,289,000 | 3 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Added | 3,535,184 | +78,431 | < 0.01% | $92,198,000 | 11 qtrs |
| Capital International Investors | Reduced | 3,525,114 | -3,073,922 | 0.02% | $91,935,000 | 11 qtrs |
| ALLIANCEBERNSTEIN L P | Added | 3,166,630 | +625,071 | 0.03% | $82,586,000 | 11 qtrs |
| STATE STREET CORPORATION | Added | 3,004,900 | +671,104 | < 0.01% | $78,368,000 | 11 qtrs |
| JPMorgan Chase & Co | Added | 2,484,735 | +102,868 | < 0.01% | $64,802,000 | 11 qtrs |
| Capital World Investors | Reduced | 2,246,577 | -26 | < 0.01% | $58,591,000 | 11 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2021
- Filed
- August 13, 2021
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 96,682
- None
- 6,505,624
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.